血管压缩剂在急性烧伤复苏中的使用:一项回顾性研究
Kristine Knappskog1,2,3, Kostiantyn Botnar4, Julia Kleinhapl2,5
1Research Group for Burn Care and Reconstructive Surgery, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.
Acta anaesthesiologica Scandinavica
|January 28, 2026
概括
血管压缩剂用于严重烧伤患者,但这项研究发现,它们的早期使用与急性损伤增加和更高的30天死亡率相关. 在烧伤护理中,需要仔细考虑血管压缩剂的使用.
科学领域:
- 关键护理医学 关键护理医学
- 燃烧管理 燃烧管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 血管压缩剂对于管理严重烧伤患者的低血压至关重要,这些患者对液体复苏无反应.
- 了解患者的特征和与血管压缩剂使用相关的结果对于优化护理至关重要.
研究的目的:
- 描述严重烧伤患者需要血管压缩剂.
- 调查早期血管压缩剂的使用与患者的结果之间的关联,包括急性损伤和死亡率.
主要方法:
- 来自TriNetX研究网络 (2010-2023) 的非识别电子健康记录的回顾性分析.
- 纳入标准:年龄≥18岁,烧伤≥20%的患者.
- 倾向性得分匹配 (1:1比) 用于比较在入院后2天内接受血管压缩剂的患者与没有接受血管压缩剂的患者.
主要成果:
- 在6872名严重烧伤患者中,有17.7%的患者早期接受了血管压缩剂.
- 血管压缩剂接受者年龄较大,患上更多的并发病,并遭受更严重的烧伤.
- 在匹配后,早期血管压缩剂的使用与急性损伤 (51.0%对28.4%),败血症 (30.8%对22.9%) 和30天死亡率 (45.1%对32.7%) 的显着较高率有关.
结论:
- 在严重烧伤患者中,早期使用血管压缩剂与风险增加有关.
- 在接受血管压缩剂的患者中观察到较高的早期急性损伤率和30天死亡率.
- 研究结果表明,需要仔细评估在烧伤复苏方案中使用血管压缩剂.
更多相关视频
相关概念视频
01:22Burn Injuries
4.4K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.4K
01:21Cardiopulmonary Resuscitation I: Adult
697
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
697
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
387
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
387
01:23Cardiopulmonary Resuscitation III: AED Use
658
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
658
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
777
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
777
01:30Acute Coronary Syndrome III: Diagnostic Studies
250
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
250